Current management of male breast cancer

Abstract

Male breast cancer represent 1% of all male cancers. The authors, by a review of literature, analyze risk factors and genic mutations involved in the development of such cancer.

They discuss instrumental procedures of diagnosis and screening, hystologic features and surgical approach of male breast cancer.

Furthermore, they suggest adjuvant therapies stressing the importance of an early diagnosis and of the absence of nodal involvement to improve the outcome of male breast cancer.